MinervaX Provides Clinical Update on its Maternal GBS Vaccine

MinervaX Provides Clinical Update on its Maternal GBS Vaccine MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces significant clinical progress on its maternal GBS vaccine.  ...

Synendos Therapeutics Appoints Scientific Advisory Board

Synendos Therapeutics Appoints Scientific Advisory Board Synendos Therapeutics (Synendos), a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to treat Central Nervous System (CNS) disorders, today announces the...

MinervaX provides clinical and leadership update

MinervaX provides clinical and leadership update MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces clinical progress on its maternal GBS vaccine as well as multiple additions to its...